Last reviewed · How we verify
NCT03443726
Is the Direct Inferior Alveolar Nerve Block Required for Third Lower Molar Extraction?
NA trial testing Nerve block technique in Tooth Extraction in 120 participants. Completed in 20 December 2018.
10 November 2018
Quick facts
| Lead sponsor | University of Barcelona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 10 June 2017 |
| Primary completion | 10 November 2018 |
| Estimated completion | 20 December 2018 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Nerve block technique
- Infiltrative technique
- 4% articaine 1:100.000 epinephrine — full drug profile →
- Third molar extraction
Conditions studied
- Tooth Extraction — all drugs for Tooth Extraction →
- Dental Anesthesia — all drugs for Dental Anesthesia →
Sponsor
University of Barcelona
Who can join
Adults 18 to 60, any sex, with Tooth Extraction or Dental Anesthesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a Randomized Controlled Trial (RCT) which objective is to compare the effectiveness, efficacy and complication associated to an infiltrative anesthetic technique for the removal of lower third molars comparing it to the standard inferior alveolar nerve block using 4% articaine 1:100.000 epinephrine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03443726
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tooth Extraction
Currently open trials in the same condition.
- NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
- NCT07154693 — Wound Healing Following Tooth Extraction and Ridge Preservation Using OsteoGen® · NA · recruiting
- NCT06806241 — Effects of Tranexamic Acid Irrigation on Impacted Third Molar Surgery · recruiting
- NCT07020767 — Effect of Two Incision Techniques on Soft and Hard Tissue Outcomes in Immediate Implant Placement in Class II Extraction · NA · active not recruiting
- NCT06473922 — Assessing Levels of Fear and Anxiety and Monitoring Wound Healing Among Patients Who Are About to Undergo Wisdom Tooth E · recruiting
Other University of Barcelona trials
Trials by the same sponsor.
- NCT07165964 — Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric · NA · recruiting
- NCT06384196 — Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression · NA · recruiting
- NCT06729697 — Pharmaceutical Literacy and Quality of Life in Spanish Population. · enrolling by invitation
- NCT06478160 — Closed-blood Sampling Devices in the Adult Critically Ill Patient · NA · recruiting
- NCT07172490 — Interdisciplinary Program to Improve Lifestyle in Chronic Pathology: Alt Pirineu Aran in Fit (APA-FIT) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03443726 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Barcelona
- Last refreshed: 31 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443726.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing